Navigation Links
Boffin Identifies Gene Causing Otosclerosis

A new study has identified a gene responsible for otosclerosis - the single most common cause of hearing loss among white adults .

Melissa Thys, from the Department of Medical Genetics, University of Antwerp, Belgium, said that this finding may be a step towards new treatments for otosclerosis, which affects approximately 1 in 250 people.

Otosclerosis is a multifactorial disease, caused by an interaction of genetic and environmental factors. The outcome is a progressive hearing loss as the growing bone in the middle ear interrupts the sound waves passing to the inner ear. While the causative factors remain unknown, now one of the genetic components has been identified.

"The gene in which the variant is located points to a pathway that contributes to the disease. This may be a lead for better forms of treatment in the future; currently the best option is an operation. However, there is often an additional component of hearing loss which can't be restored by surgery," Thys said.

As the gene involved is a growth factor, and the disease manifests itself by the abnormal growth of bone in the middle ear, it may have a large potential for therapy", she added. Thys and her team decided to study a gene called TGBF1 which they already knew had non-genetic indications of involvement in otosclerosis: it plays a role during embryonic development of the ear and is expressed in otosclerotic bone.

They used SNP (single nucleotide polymorphism) analysis, or looking at DNA sequence variations occurring in a single nucleotide, A, T, C or G, to study a large patient and control population from Belgium and The Netherlands. They found significant results for an amino acid changing SNP inTGBF1, and that this remained significant after correcting for multiple testing. Analysis of a large French group showed the same association.

"Combining the data from both groups with a common odds ratio gave a very signific
'"/>




Page: 1 2

Related medicine news :

1. Fizzy Logic For A Perfect Drink: Courtesy Boffins
2. Boffins Identify Fifth Gene Behind Joubert Syndrome
3. Boffins Find Link Between Common Sleep Disorder and Hypertension
4. Boffins Identify Molecule That Might Treat Food Allergy
5. Boffins a Step Closer to Solving Puzzle of Lou Gehrigs Disease
6. Boffins Identify Gene That Helps Regulates Body Weight
7. Boffins Link Atkins Diet With Bowel Cancer
8. Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA
9. Research Identifies The Causes Of Snoring
10. New Test Identifies Candidates For Cardiac Defibrillator
11. Research Identifies Osteoporosis Controlling Protein
Post Your Comments:
(Date:1/7/2009)... Myers, Inc.,(NYSE: RBN ) today reported diluted...scal first quarter ended November 30, 2008, as com... First quarter 2009 sales increased 3% over the,pr... decreased 5% to $185,million. Excluding the impa...ation, organic sales increased 6% and organic orde...
(Date:1/7/2009)...on pediatric cancer , , WEDNESDAY, Jan. 7 ...redicts which children with acute lymphoblastic le..., reported online Jan. 7 in the New England Journ...cians fine-tune treatment for different subsets of... leukemia (ALL) is really one of the success stori...
(Date:1/7/2009)... D and the brain disease , , WEDNESDAY, Ja...ed nine genes that might make people more likely t... confirmed earlier reports that a variation in the... also increase risk for Alzheimer,s. Low levels o...er,s and other dementias, leading researchers to s...
(Date:1/7/2009)...nd Convenience , , CARLSBAD, Calif., Jan. 7 Ski... on-line service for physicians and patients to ac... products. The new Web site, www.skinmedica.com ,...eir physicians while offering the convenience of o...ttp://www.newscom.com/cgi-bin/prnh/20090107/LA5640...
Breaking Medicine News(10 mins):Health News:Robbins & Myers Announces First Quarter 2009 Results 2Health News:Robbins & Myers Announces First Quarter 2009 Results 3Health News:Robbins & Myers Announces First Quarter 2009 Results 4Health News:Robbins & Myers Announces First Quarter 2009 Results 5Health News:Robbins & Myers Announces First Quarter 2009 Results 6Health News:Robbins & Myers Announces First Quarter 2009 Results 7Health News:Robbins & Myers Announces First Quarter 2009 Results 8Health News:Robbins & Myers Announces First Quarter 2009 Results 9Health News:Gene Governs Response to Leukemia Chemotherapy 2Health News:9 Genes Are Linked to Alzheimer's 2Health News:SkinMedica Launches On-Line Service for Physician Partners 2
...ding to Dr. Dworkin, a Maryland anesthesiologist a... who has authored: "Artificial Unhappiness: The ...medicating unhappiness. "Too many people take drug...anges in their lives, he says. For Dworkin, statis...
...ion drugs may give a man's performance in bed a bo...self-esteem or their relationships . A survey of...le problems have poorer esteem, a weaker sense of ...ersonal satisfaction. Of these 400 men had erecti...
...dy of more than 2,200 women at the Kimmel Cancer C...can American women have more advanced breast cance... In addition, African American women tend to have... more aggressive and have poorer prognoses. The fi...
...ns have discovered a genetic marker that increases... The 10-year study was conducted by a team of res...chool and U-M School of Public Health, the Catalan...e CHS National Israeli Cancer Control Center and T...
Other Medicine News:Health News:Americans Bloated On Happy Pills 2Health News:Afro- American Women Have More Aggressive Breast Cancer 2Health News:Afro- American Women Have More Aggressive Breast Cancer 3
(Date:1/7/2009)... Jan. 7 Tiantan Puhua Hospital Ste...the worldwide leader in using stem cells to effect...y six new globally experienced additions to its me... the hospital,s treatment capabilities for growing...ix senior doctors include the distinguished Dr. Ji...
(Date:1/6/2009)..., Jan. 6 The Michael J....ion to four industry research teams for pre-clinic...son,s disease. , , The funding was awarded unde...ative. This program, first launched in 2006, supp...inson,s research. TDI is part of MJFF,s focus on...
(Date:1/5/2009)...O, Jan. 5 Cylene Pharmaceuticals a...nical trial of its oral CK2 protein kinase inhibit...s, Castleman,s disease, or multiple myeloma. The p... are determination of safety, tolerance and PK pro...ose for Phase II trials. In addition, multiple mec...
(Date:12/29/2008)..., Md., Dec. 29 The winn...rch Protection was announced today by Dr. Peter G....Improvement Institute. , , The winner of the a...nderson Cancer Center -- for its best practice "...gram provides for 1) enhanced human subjects prote...
Breaking Medicine Technology:Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 32008 Human Research Protection Award Recipients Announced 2Mathematics might save you a trip to the ER 1066 1Mathematics might save you a trip to the ER 1066 2ReBuilder Medical Technologies Inc Reports International Sales Expansion 1063 1ReBuilder Medical Technologies Inc Reports International Sales Expansion 1063 2ReBuilder Medical Technologies Inc Reports International Sales Expansion 1063 3ReBuilder Medical Technologies Inc Reports International Sales Expansion 1063 4Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia 28STA 28TM 29 29 System and Compudent 28TM 29 1058 1Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia 28STA 28TM 29 29 System and Compudent 28TM 29 1058 2Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia 28STA 28TM 29 29 System and Compudent 28TM 29 1058 3Discover Testing Settles the Drinking Water Debate 3A Tap vs Bottled 513 1Discover Testing Settles the Drinking Water Debate 3A Tap vs Bottled 513 2
Inquire
EDTA K2 / gel tubes are for the examination of EDTA plasma for molecular diagnostics and for viral load determinations. HIV and HCV in whole blood remain stable at room temperature for up to 72 hours
Glass Whole Blood Tube with K3EDTA
...minase (tTg) is a ubiquitous enzyme that catalyzes...inase is also the specific protein that is identif...(EMA) tests (Bio-Rad catalog number 29003 and 2906...hly sensitive and specific for celiac disease diag...
Medicine Products: